Integral Molecular, Inc. Identifies Potent Antibody Antagonists Against Ion Channel Pain Target P2X3

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular, a leader in membrane protein antibody discovery, announces that it has successfully generated potent antibody antagonists targeting the P2X3 ion channel using the MPS Discovery EngineTM, its proprietary strategy for antibody elicitation and optimization, in conjunction with Crystal Bioscience’s proprietary GEM technology for isolating unique monoclonal antibodies from immunized chickens.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC